SB240: AN ACT relating to Ibogaine research in the Commonwealth.
Legislative Summary
Create new sections of KRS 218A to define terms; establish the intent of the General Assembly that ibogaine is worthy of clinical research, trials, and studies as a potential viable therapeutic treatment of opioid dependence and any other co-occurring mental health disorders; establish a trust and agency account entitled the ibogaine research fund; establish a process for private entities to apply to the Department of Agriculture for access to funds in the Ibogaine Research Fund.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
